Genetically-encoded macrocyclic peptide libraries bearing a pharmacophore
The present invention relates to a method of forming a macrocyclic peptide bearing a pharmacophore and said produced macrocyclic peptide, wherein the method comprises the steps of: reacting a peptide with two thiol groups of cysteine side chains with the reactive compound 1,5-dichloropentanedion-2,4. The reaction between the reactive compound and the peptide produces an 1,3-diketone-containing macrocyclic polypeptide. The macrocycle with a 1,3-diketone group is then modified by reaction of said macrocycle with an alkyl or aryl hydrazine group bearing a pharmacophore in benign aqueous conditions. The macrocycles may be displayed in a library, such as a phage display library, and used to biopan for affinity against a selected target.
1. A macrocyclic polypeptide comprising a linear peptide portion comprising X L CysX M CysX N , where X is any natural amino acid, L is an integer from 2-20, M is an integer from 2 to 10, and N is zero or an integer from 1 to 20, and a diazole moiety formed from the reaction between a diketone linchpin and the cysteine residues and a subsequent reaction with an alkyl or aryl hydrazine, wherein the diazole moiety bears a pharmacophore.
2. The polypeptide of claim 1 , wherein the polypeptide is genetically encoded by and linked to a nucleic acid.
3. A mixed peptide library comprising two or more libraries, each comprising a plurality of polypeptides as claimed in claim 1 , wherein each library comprises a silent genetic barcode which distinguishes between the two or more libraries on a genetic level, but which are phenotypically identical, and each library has been separately modified with a different pharmacophore.
4. The mixed peptide library of claim 3 which is a phage library.
5. A method of identifying a pharmacophore with specificity to a target, comprising screening the mixed library of claim 3 with the target.
6. The polypeptide of claim 1 , wherein the subsequent reaction is with an alkyl hydrazine.
7. The polypeptide of claim 1 , wherein the subsequent reaction is with an aryl hydrazine.